<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Alterity Therapeutics Limited

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases. Alterity Therapeutics was incorporated in Melbourne, Australia in 1997 as Prana Biotechnology and has offices in Melbourne, Australia, and San Francisco, USA. The Company listed on the Australian Securities Exchange in 2000 and listed on the NASDAQ in 2002. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Geoffrey Kempler
    • FOUNDED
      1997
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    Neurocarrus Inc

    Neurocarrus Inc

    Neurocarrus is developing a breakthrough therapy ( N-001 ) to fulfill the unmet ne...

    Neurocarrus is developing a breakthrough therap...

    Amount Raised:    $344,168.00
    Fundraising Status:    EC
    Filing Type:    CF
    GenMark Diagnostics, Inc.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...

    GenMark Diagnostics (NASDAQ: GNMK) is a leading...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Stoke Therapeutics, Inc.

    Stoke Therapeutics, Inc.

    Stoke is pioneering a new way to treat the underlying cause of severe genetic dise...

    Stoke is pioneering a new way to treat the unde...

    Filing Type:    PU
    Orgenesis Inc.

    Orgenesis Inc.

    Orgenesis is a vertically-integrated biopharmaceutical company with unique experti...

    Orgenesis is a vertically-integrated biopharmac...

    Filing Type:    PU
    WindowMirror Inc

    WindowMirror Inc

    WindowMirror's BUTTERFLY will be a collaborative SaaS (Software as a Service) plat...

    WindowMirror's BUTTERFLY will be a collaborativ...

    Amount Raised:    $14,462.00
    Fundraising Status:    EC
    Filing Type:    CF
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.